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Lymphokines (LK) t are polypeptides that mediate many of the regulatory func-
tions of the immune system . Among these are a set of molecules that are produced
by T cells in response to receptor-mediated stimuli and act upon B lymphocytes,
macrophages, other cells of hematopoietic lineage, and on the T cells themselves
(1). It has recently been demonstrated that crosslinkage of Fc receptors on growth
factor-dependent mast cell and myeloid cell lines stimulates the production ofsome
of these "T cell-derived"molecules, including IL-4, IL-5, IL-3, and granulocyte/mac-
rophagecolony-stimulating factor(GM-CSF) (2-5) . Non-transformed mast cell lines
have also been reported to secrete IL-6, IL-1, TNFa and several of the macrophage
inflammatory proteins in response to cross-linkage, of high affinity FcE receptors (3, 5) .
We have recently shown that a population ofspleen cells that lack both B cell and
T cell markers and do not express the NK cell marker asialo-GM1 on their surface
produce IL-4 in response to incubation on culture dishes coated with IgE (6) . The
response of these cells to plate-bound (PB) IgE is inhibited by low concentrations
of soluble IgE, strongly suggesting that it is mediated by cross-linkageofahigh affinity
FcE receptor. The production of IL-4 by splenic non-B, non-T cells from untreated
mice in response to PB-IgE is markedly enhanced by the presence of IL-3 . In the
presence ofIL-3, PB-IgGI, IgG2a, and IgG2bare also potent stimuli ofIL-4 produc-
tion by splenic non-B, nonT cells from naive animals .
In this report, we examine the changes in the LK-producing capacity of the non-
B, nonT cell population in mice that have been injected with anti-IgD antibodies
as well as in mice that havebeen infected with the helminthic parasite Nippostrongylus
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brasiliensts (Nb). Both anti-IgD injection and infection with Nb elicit an immune
response marked by production of large amounts of polyclonal IgE (7, 8). We chose
these immunization protocols, which cause IgE to be formed in large amounts, be-
cause it has been shown that IL-4 is essential for in vivo IgE responses (9) and be-
cause increased IL-4 production has been reported in one of these situations (10).
We show here that mice that have received anti-IgD antibodies or have been in-
fected with Nb exhibit a considerable increase in the number of splenic non-B, non-
T cells. Furthermore, non-B, non-T cells from mice that have received injections
with anti-IgD or have been infected with Nb produce much more IL-4 in response
to PB-IgE or PB-IgG2a than do such cells from normal mice and can do so without
need for the addition of IL-3. These striking changes in IL-4-producing non-B, non-T
cells suggest that such cells may play a physiologic role in responses to agents that
elicit immune responses marked by elevation of serum IgE levels.
Materials and Methods
Animals.
￿
Virus-free female BALB/c mice, 8-12 wk old, were obtained from Division of
Cancer Therapy Animal Program, National Cancer Institute. Nb infection was performed
by subcutaneous injection of 1,000 Nb larvae. Goat-mouse IgD antibodies (800 ttg) were
injected in the tail vein.
Culture Medium.
￿
RPMI 1640 (Biofluids, Rockville, MD) supplemented with 10% FCS
(HyClone Laboratories, Logan, UT), L-glutamine (2 mM), 2-ME (0.05 mM), Hepes (10
mM), penicillin (100 U/ml), and streptomycin (100 1~g/ml) was used for culturing cells.
Preparation of Non-B, Non-T Cells; B Cells; and T Cells.
￿
Single cell suspensions were pre-
pared from spleens, lymph nodes, or thymus in cold HBSS. Marrow cell suspensions were
prepared by repeated flushing offemoral marrow cavities with cold HBSS through a 23-gauge
needle. Single cell suspensions from lungs were prepared by enzymatic digestion of washed
lungs by three cycles of incubation each for 30 min at 37°C in culture medium containing
5% FCS, IOOU/ml collagenase (Type 11; Sigma Chemical Co., St. Louis, MO), 30 U/ml DNase
(Type I; Sigma Chemical Co., St. Louis, MO), 0.05% soybean trypsin inhibitor. The lung
cell suspensions were fractionated on Percoll density gradients (Pharmacia Fine Chemicals,
Uppsala, Sweden). The cells were layered onto discontinuous gradient (70, 66, 60, and 50%
Percoll) and centrifuged at 1,000 g for 20 min at room temperature. The cells in the inter-
phase between 50 and 60% Percoll were washed twice with cold HBSS and used as lung
cell suspensions.
Red blood cells (from spleen and bone marrow) were lysed by suspension ofcells in ammo-
nium chloride-potassium carbonate lysing buffer. Nucleated cells were washed 2 x in HBSS
and suspended in culture medium containing 5 mM EDTA (staining buffer). Depletion of
T and B cells, that had been stained with a mixture of FITC-labeled antiT and anti-B re-
agents, with magnetic beads coated with sheep anti-FITC, was performed as described previ-
ously (6). The FITC-labeled antibodies used were antiThy-1.2 (30H12), anti-CD3 (2C11),
anti-.CD4 (Gk1.5), anti-CD8 (2.43), anti-B220 (6B2), and anti-Iad (MKD6). Efficiency of
depletion was determined by cytometric analysis using a FACScan (Becton Dickinson & Co.,
Mountain View, CA).
Lymphokines and Cytokines.
￿
Human rIL-2 was a gift ofCetus Corp. (Emeryville, CA). IL-2
activity was defined in terms of"Cetus Units." 1 Cetus Unit is equivalent to 6 WHO interna-
tional units. Synthetic IL-3 was a gift of Dr. Ian Clark-Lewis (Biomedical Research Center,
Vancouver, Canada). 1 U of IL-3 was defined as the amount of IL-3 that stimulated half
maximal [3H]thymidine incorporation by FDC/1 cells. Mouse rIL-4 was obtained from a
baculovirus expression system, using a vector into which the IL-4 gene had been inserted
by C. Watson, Laboratory of Immunology, NIAID. IL-4 activity was measured using the
CTAS cell line (11), comparing it with a standard that had initially been calibrated on the
basis of 10 U/ml being equal to the amount of IL-4 required for half maximal stimulationCONRAD ET AL.
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of [3H]thymidine uptake by resting B cells stimulated with 5 Jig/ml of goat anti-IgM anti-
body (12).
Immunoglobulins and Monoclonal Antibodies.
￿
Purified mouse IgG1, IgG2a, and IgG2b were
purchased from Southern Biotechnology (Birmingham, AL). Mouse IgE anti-DNP mAb
(HI-DNP-e-26) (13) was purified from ascites fluid by ammonium sulfate precipitation, DE52
ion-exchange chromatography and gel filtration (14). Purified monoclonal rat anti-mouse IL-4
(11B11) (15) was prepared by Verax Corp. (Hanover, NH). (Fab')2 goat anti-mouse IgG Fc
was purchased from Organon-Cappel (West Chester, PA). (Fab')2 anti-mouse IgE was pre-
pared by pepsin digestion of monoclonal rat anti-IgE (BlE3) followed by purification by gel
filtration.
The following antibodies were prepared by a combination of ammonium sulfate precipita-
tion, DE52 ion-exchange chromatography, and Sephadex G200 gel filtration (16); antiThy-
1.2 (30H12) (17); anti-CD3 (2C11) (18); anti-CD4 (Gk1.5) (19); anti-CD-8 (2.43) (20); anti-
B220 (6B2) (21); and anti-Iad (MKD6) (22). Purified Ig was fluoresceinated with FITC, as
previously described (23). Affinity purified goat anti-mouse IgD antibody was prepared as
described elsewhere (16).
Measurement ofIl-4 Productionfrom Cells Stimulated by PB Antibodies.
￿
Non-B, non-T cells were
cultured for 36 h in 96-well microtiter Immulon-2 plates that had been coated with 10 Jig/ml
of the indicated Ig. After irradiation (1,000 rad), 5000 CT4S cells (11) were added per well
and IL-4 production was determined by an 8-h pulse with ["H]thymidine 48 h later. Anti-
IL-2 mAb (111511) completely inhibits ['H]thymidine uptake by CT4S cells that have been
cocultured with non-B, non-T cells stimulated with PB-1g. This indicates that IL-4 was the
lymphokine whose production was measured by this assay. All determinations were performed
in triplicate; relative standard errors had a mean of <15 ° Jo. IL-4 production is shown as ei-
ther direct cpm incorporated or IL-4 equivalent units, determined from a standard curve
performed with the CT4S cells in the same assay using known concentrations of added rIL-4.
Nb Antigen.
￿
Secretory antigen from adult Nb worms was isolated as described byJarboe
et al. (24). Briefly, adults worms were rinsed out of the upper one-third of the small intestine
of rats injected 12 d previously with 3,000 Nb larvae. The worms were washed with RPMI
1640, placed in petri dishes in RPMI 1640 with antibiotics (penicillin, streptomycin, and
gentamicin) and incubated for 48 h. The supernatant was then filtered and the protein con-
tent determined by the Bradford assay.
Results
Injection ofAnti-IgD and Infection with Nb Increases the Number ofSplenic Non-B, Non-T
Cells and Their Production ofIL-4. The spleens of normal mice contain a population
of cells that lack the B and T cell markers Thyl, CD3, CD4, CD8, la, and 15220
(Fig. 1). In mice that have been injected with anti-IgD antibodies 5 d earlier or in-
fected with Nb larvae 9 d earlier, there is a striking increase in the fraction of spleen
cells in the non-T category. In the experiments illustrated in Fig. 1, 20.9% of spleen
cells from Nb-infected and 19.8% of spleen cells from anti-IgD-injected mice are
non-B, non-T cells while the controls (spleen cells from naive mice) for these experi-
ments were 6.4 and 2 .5%.
Non-B, nonT cells were purified from spleens ofnormal BALB/c mice and from
spleens of anti-IgD-injected and Nb-infected BALB/c mice through the use of anti-
FITC-conjugated to magnetic beads to deplete cells that had bound FITC anti-
bodies specific for the markers listed in the paragraph above. To test the IL-4-producing
capacity of non-B, non -T cells from these mice, varying numbers of cells were cul-
tured in 96-well dishes to which IgE had been adsorbed. Since non-B, nonT cells
from naive mice require the presence of IL-3 for optimal IL-4 production in re-
sponse to PB-IgE (5), IL-3 was added to all cultures. As shown in Fig. 2, 3 x 1031500 IL-4 PRODUCTION BY NON-B, NON-T CELLS FROM IMMUNE MICE
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FIGURE 1.
￿
Nb infection and injection of anti-IgD markedly increase the frequencyof splenic
non-B, nonT cells. Spleen cells from Nb-infected mice and from anti-IgD-injected mice were
compared with normal controlanimals(untreated) forfrequencyofnon-B, nonT cells by staining
with FITC-conjugated antiThy-1, CD3, CD4, CD8, 13220, and la antibodies andexamined by
FAGS analysis. Thepercentages shown refer to cells not stained by these antibodies. Thehisto-
grams shown here reflect two separate experiments. The results for cells from the Nb infected
and untreated mice (left histograms) ..rereported as relative fluorescence intensity, while those
forcells from anti-IgD-injected and untreated mice (right histograms) are reported as fluores-
cence channel number. In both cases, the data were collected usinglogarithmic amplification.
non-B, non-T cells from Nb-infected mice make an amount of IL-4 comparable to
that made by 105 non-B, non-T cells from normal mice. A similar amount of IL-4
is made by 104 non-B, nonT cells from anti-IgD-injected mice. These results thus
indicate a striking increase in the capacity of non-B, nonT cells from both groups
of mice to produce IL-4.
To be certain that IL-4 was produced by non-B, non-T cells, we harvested cells
at the end of the culture period and stained them with anti-13220, CD-3 and anti-
Thy-1. The cells failed to stain with these reagents (data not shown) indicating that
the responses of the non-B, non-T cell population could not be accounted for by
a small number of either B or T cells that had not been eliminated in the initial
purification and had been expanded during the culture period. Furthermore, we
have previously shown (6) that neither B cells nor T cells prepared from the same
starting population as the non-B, nonT cells produced IL-4 in response to PB-Igs,
indicating that non-B, nonT cells were the sole population in the spleen responsible
for IL-4 production in response to Fc receptor crosslinkage.
We have evaluated total numbers of spleen cells and percentages of non-B, non-T
cells from normal and anti-IgD-injected mice in a series of experiments. Thus,
anti-IgD-injected mice yield 1.09 ( ± 0.21 SE) x 108 cells per spleen while the meanW
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FIGURE 2.
￿
IL-4 production by non-B, non-T
cells is enhanced by Nb-infection or anti-IgD in-
jection. Non-B, nonT cells from spleens ofnaive,
goat anti-IgD-injected (5 d earlier) or Nb-infected
(9 d earlier) mice were incubated at various cell
densities on IgE-coated wells (10 hg/ml) in the
presence ofIL-3 (50 U/ml). After 36 h, the cells
were irradiated (1,000 rad) and CT4S cells were
added (5,000 cells/well). [3H]Thymidine was
added 48 h laterand incorporation into the DNA
was determined after 10 h.
number of spleen cells obtained from naive BALB/c mice was 0.41 ( ± 0.03) x 10".
The percentage of non-B, non-T cells in anti-IgD-injected spleens was 13.3 ( ± 1 .6),
while in normal spleen cell populations it was 7 .8 ( t 1 .0). Thus anti-IgD mice have
4.7-fold more splenic non-B, non-T cells than do normal mice. Since these cells are
N10-fold better on a per cell basis in producing IL-4, the overall increase in these
mice is on the order of 50-fold. Although similar comparisons have not been per-
formed with for Nb-infected mice, the absolute increase in the size of the splenic
non-B, non-T cell population is at least as great as in the anti-IgD mice, and as
shown above, the increase in production per cell is even larger, indicating a greater
increase in IL-4-producing capacity of spleen cells from these mice.
Not only are non-B, non-T cells more numerous in the spleens of Nb-infected
and anti- IgD-injected mice, these cells can also produce substantial amounts of IL-4
in the absence of IL-3 (Fig. 3). The addition of IL-3 further increases the IL-4
producing capacity of these cellsbut their dependence on IL-3 is much less dramatic
than is the case for IL-4 production by non-B, non-T cells from naive mice in re-
sponse to PB-IgE.
Non-B, Non-TCellsfrom Nb-infected orfrom Anti-IgD-injectedMice Produce IL-4 in Re-
sponse to Anti-IgAntibodies or to Antigen. Non-B, non-T cells from mice infected with
Nb larvae 9 d earlier produced IL-4 when cultured on dishes to which an Nb antigen-
containing extract had been adsorbed (Fig. 4). By contrast, non-B, non-T cells from
naive mice, even in the presence of IL-3, failed to produce IL-4 in response to Nb
antigen. This strongly suggests that Fc receptors on non-B, non-T cells from Nb-
infected mice have bound antibody specific for Nb antigen and crosslinkage of these
receptors by antigen leads to stimulation of lymphokine production.
To further examine the role of Ig bound to non-B, non-T cells as a target for cross-
linkage and subsequent stimulation of IL-4 production, we examined the capacity
of F(ab')2 fragments of heavy chain-specific anti-IgE and anti-IgG antibodies to
simulate IL-4 production by cells from mice that had not been injected with anti-
IgD (day 0 mice) or at 6 and 16 d after injection (Fig. 5). In the absence of IL-3,
non-B, non-T cells(12,500/well) from day 0 mice failed to produce detectable amounts
of IL-4 in response to PB-IgE or PB-IgG2a. PB anti-IgE also failed to stimulate1502 IL-4 PRODUCTION BY NON-B, NON-T CELLS FROM IMMUNE MICE
V
W
Y
Q
W
O
T
100000 I NbINFECTED AROUSE
.10000
0
"ANTI-191)MOUSE" NAIVEMOUSE
~
7
￿
3
￿
. . . .
￿
., , .
￿
. . . . . .,
3
.
￿
,.-,
￿
.
￿
- . .- . ., ` .
￿
. .
￿
.
S
0 10 10 10 10 10 5 1 10 10
CELLSIWELL
FIGURE 3 .
￿
Non-B, non-T cells from Nb-injected or anti-IgD-injected mice produce substantial
amounts of IL-4 in the absence of IL-3 . Non-B, nonT cells from spleens of naive, goat anti-IgD-
injected (5 d earlier) or Nb-injected mice (9 d earlier) were incubated at various cell densities
on IgE-coated wells (10 Ag/ml) in the presence or absence ofIL-3 (50U/ml) . (These are the same
cells as were used in the experiment illustrated in Fig. 2.) IL-4 production was measured by co-
culture with CT4S cells as described in the legend to Fig . 2 .
a response while PB anti-IgG did elicit production ofmodest levels of IL-4 . In the
presence of IL-3, all the stimulants elicited production of some IL-4 from non-B,
non-T cells from naive mice . Anti-IgE was a poorer stimulant than anti-IgG . How-
ever, injection of anti-IgD caused a substantial increase in IL-4 production in re-
sponse to anti-IgE, which was noted on both days 6 and 16 . There was also an in-
crease in IL-4 production in response to anti-IgG . These results are consistent with
the striking increases in IgE and IgG1 levels that occur in anti-IgD-injected mice
beginning at about 6 d and indicate that Ig bound to non-B, nonT cells in vivo
can act as a"receptor" for stimulation of IL-4 production, presumably by the cross-
linkage of Fc, and of Fcy receptors to which the Igs were bound .
It should also be noted that some IL-4 is produced by non-B, nonT cells from
Nb-infected (Fig . 4) and anti-IgD-injected mice (Fig . 5) in response to IL-3 alone .
The mechanism for this has not been determined, but might reflect the enhance-
FIGURE 4 .
￿
Nippostrongylus antigen
triggers IL-4 production by non-B,
nonT cells from Nb-infected mice .
Non-B, nonT cells (20,000/well) from
the spleens of naive or Nb-infected (9
d earlier) mice were cultured in the
presence of IL-3 on microtiter wells
that had been coated with nothing or
Nb extract (10 Wg/ml). IL-4 production
wasmeasured by co-culture withCT4S
cells as describedin the legendto Fig . 2 .FIGURE 5.
￿
PB-Ig and anti-Ig
induces IL-4 production by
non-B, non-T cells at various
times after anti-IgD injection.
Non-B, nonT cells from the
spleens of naive or anti IgD-
injected mice (6 or 16 d earlier)
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ment by IL-3 of a "weak" crosslinking of Fc,y or Fc, receptors caused by the pres-
ence of some immune complexes bound, in vivo, to these receptors.
Organ Distribution of IL-4 Producing Non-B, Non-T Cellsfrom Naive and Nb-infected
Mice. Non-B, non-T cells were prepared from spleen, bone marrow, thymus, and
mesenteric lymph node of untreated mice. PB-IgE, in the presence of IL-3, caused
considerable IL-4 production by splenic non-B, nonT cells. Bone marrow cellspro-
duced even more IL-4 in response to PB-IgE and to PB-IgG2a than did splenic non-B,
nonT cells (Fig. 6). By contrast, no production of IL-4 in response to PB-Ig was
obtained from mesenteric lymph node or thymus non-B, nonT cells. In other ex-
periments (not shown), peritoneal non-B, nonT cells also failed to produce IL-4
in response to PB-Ig in the presence of IL-3.
Anti-IgD-injected and Nb-infected mice showed striking production of IL-4 from
splenic and bone marrow non-B, nonT cells (data not shown). However, even in
these mice non-B, nonT cells prepared from lymph node, thymus, or peritoneum
did not produce IL-4 in response to PB-Ig. Since Nb larvae migrate through the
lung before maturing into adultworms in the intestinal tract ofthe mouse, we exam-
ined the IL-4 producing capacity of non-B, nonT cells in the lungs of Nb-infected
mice. These cells produced considerable amounts of IL-4 in response to PB-IgE,
PB-IgG2a or PB F(ab')2 anti-IgG while lung non-B, nonT cells from normal or
anti-IgD-injected mice did not respond to these stimulants (Fig. 7). It should be
noted that, IL-3 alone stimulated IL-4 production from lung non-B, nonT cellsfrom
Nb-infected mice.
Discussion
The capacity of transformed mast cells to constitutively produce IL-4 (25) and
of nontransformed mast cell lines to produce IL-4 and other lymphokines in response1504
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FIGURE 6 .
￿
Non-B, non-T cells from bone marrow but notthymus or lymphnodes produce IL-4
in response to PB-Ig. Non-B, nonT cells from the spleens, lymph nodes, thymus, or bone marrow
of naive mice were incubated in culture medium containing IL-3 (50 U/ml) on wells (25,000
cells/well) that had been coated with nothing, IgG2a, or IgE (10 fcg/ml) . IL-4 production was
measured by co-culture with CT4S as described in the legend to Fig . 2 .
to Fc E receptor crosslinkage (3-5) raised the possibility that normal counterparts of
these cells might be importantphysiologic producersof IL-4 . Other previous results
indicated thatT -depleted splenocytes from Nb infected mice produced IL-4, as de-
termined by maintenance of Fc,RII levels and that the optimum IL-4 production
was seenon days 9-11 post-Nb infection (26) . Recently, using a more sensitive assay,
we demonstrated thata spleen cell population lacking bothTcell andB cell markers
produced substantial amounts of IL-4 in response to stimulation with PB-IgE (6) .
This response appears to be mediated by crosslinkage of Fc fRl, and when cells are
obtained from naive mice, is markedly enhanced by treatment of cells with IL-3 .
These cells are not mature mast cells, since mature mast cells are not found in the
non-B, non-T cell population obtained from spleens of naive mice . We have sug-
gested that mast cell precursors may be the cell population mediating this effect,
but definitive evidence establishing this has not been obtained . Theorgan distribu-
tion of IL-4-producing non-B, nonT cells (spleen and bone marrow but not lymph
FIGuRE 7 .
￿
Non-B, non-T cells inlungs
of Nb-infected mice produce IL-4 in
response to FcR crosslinkage. Non-B,
non-Tcells from thelungs ofnaive, goat
anti-IgD-injected (5 d earlier) or Nb-
infected (9 d earlier) mice were incu-
bated in medium containing IL-3 (50
U/ml) on microtiterwells (20,000 cells/
well) that had been coated with noth-
ing, IgE, IgG2a, or (Fab')2 goat anti
mouseIgG (10hg/ml) . IL-4 production
wasmeasuredbyco-culturewithCT4S
cells as described inthelegend toFig. 2 .CONRAD ET AL.
￿
1505
node, thymus, Peyer's patch, or peritoneum) is consistent with the cell being a he-
matopoietic progenitor cell.
IL-4 production has also been shown to be mediated by stimulation with PB-Ig's
of the IgG2a, IgGl, and IgG2b classes (6). Both Nb-infected and anti- IgD-injected
mice show striking enhancement in their production of IL-4 in response to both
PB-IgE and PB-IgG2a. Although it is not clear whether the cells that produce IL-4
in response to PB-IgG are the same as those that respond to PB-IgE, the receptors
through which the effects are mediated are distinct. Thus, soluble IgE is an effective
inhibitor of IL-4 production in response to PB-IgE but not in response to PB-IgG2a
while the monoclonal anti-Fc-yR2 antibody 2AG2, inhibits IL-4 production in re-
sponse to PB-IgG2a but not to PB-IgE (6).
The current studies show that in two situations in which there are striking in-
creases in serum IgE levels, there are parallel increases both in the numbers of spleen
cells that lack T cell and B cell markers, and in the amount of IL-4 produced by
a standard number ofthese non-B, non-T cells. Thus, in mice injected with anti-IgD
antibodies and in animals infected with Nb larvae, 10-33-fold fewer non-B, nonT
cells are required for the production of a standard amount of IL-4 than is the case
for non-B, non-T cells from normal mice. Furthermore, spleens from anti-IgD-injected
mice contain more than four times as many non-B, non-T cells as do spleens from
naive mice.
In addition to an increase in the IL-4-producing capacity of the splenic non-B,
non-T cell population of Nb-infected and and of anti-IgD-injected mice, these cells
produce considerable amounts of IL-4 without a requirement for addition of IL-3,
whereas cells from naive animals are strikingly dependent upon the addition of IL-3
to the culture.
IL-4 production by cells from Nb-infected and anti-IgD-injected mice can be elicited
not only by PB-IgE but also by PB-F(ab')2 fragments of anti-IgE antibodies, sug-
gesting that the Fc, receptors of these mice have bound IgE in vivo and thus can
be indirectly crosslinked by anti-IgE in vitro. Similarly, we observed that splenic
non-B, nonT cells from Nb-infected mice can be stimulated to produce IL-4 by
an antigen extract derived from Nb worms. This indicates that antigen can crosslink
specific antibodies bound to Fc receptors on non-B, nonT cells and lead to IL-4
production. In this situation, we have not determined whether the antibody in ques-
tion is cell-associated IgG or IgE. It should be noted that anti-IgG antibodies are
also excellent stimulants of IL-4 production by non-B, nonT cells and that this stim-
ulant acts efficiently both on cellsfrom naive donors and from immune donors. These
results indicate that antigen as well as antigen-antibody complexes could be in vivo
stimulants of IL-4 production by non-B, non-T cells, providing a potential physio-
logical means for lymphokine production by these cells.
One unexplained observation is that non-B, nonT cells in immune mice produce
measurable amounts of IL-4 in response to treatment with IL-3 only. One possi-
bility is that these cells have bound IgE or IgG that is minimally crosslinked providing
a signal too modest to elicit IL-4 production without the presence of added IL-3 .
Alternatively, IL-3 may, under certain conditions, directly stimulate lymphokine
production from "activated" non-B, nonT cells.
Overall, these experiments indicate that the IL-4 producing capacity of non-B,
nonT cells expands dramatically in Nb infection and in association with anti-IgD1506
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injection. This strongly suggests that these cells have an important role to play in
the regulation of responses associated with these forms of immunization. Further-
more, the fact that the cells become less IL-3-dependent after immunization than
was the case for non-B, non-T cells from naive animals could be explained by the
action of IL-3 upon these cells in vivo. We (LeGros, G., S. Z. Ben-Sasson, D. H.
Conrad, I . Clark-Young, M . Plaut, F. D. Finkelman, and W. E. Paul, manuscript
in preparation) have observed that IL-3 injection into mice increases IL-4 produc-
tion from peritoneal and splenic non-B, non-T cell populations. If IL-3 is required
in vivo for the expansion and relative IL-3 independence of immune non-B, nonT
cells, this would suggest that the immunization effects observed might result from
T cell production of IL-3 . Thus, the production of lymphokines by non-B, non-T
cells might very well reflect a means through which T cell function could be strik-
ingly amplified in vivo by recruitment of a "new" IL-4-producing cell population.
Summary
Non-B, non-T cells from spleen and bone marrow of naive mice produce IL-4
upon stimulation by plate-bound IgE or IgG2a in the presence of IL-3. Infection
ofmice with Nippostrongylus brasiliensis (Nb) or injection ofanti-IgD antibodies, treat-
ments known to cause striking polyclonal IgE responses, increase the number of
splenic non-B, nonT cells and cause 10-30-fold increase in IL-4 production by a
standard number ofthese cells. In Nb-infected mice, IL-4 producing non-B, non.T
cells can be found in the lungs, a site through which Nb larvae migrate. Non-B,
nonT cells from anti-IgD-injected mice produce IL-4 in response to anti-IgE anti-
bodies, indicating that these cells have been sensitized in vivo with IgE and that
crosslinkage of such IgE can lead to stimulation of lymphokine production. Simi-
larly, non-B, non-T cellsfrom Nb-infected mice produce IL-4 upon stimulation with
Nb-antigen, indicating that antigen can also crosslink receptors on in vivo sensitized
non-B, nonT cells and stimulate lymphokine production . The striking increases in
the IL-4-producing capacity of the splenic non-B, nonT cell population in anti-IgD-
injected and Nb-infected mice and the in vivo sensitization of these cells strongly
suggests that they may have an important role in lymphokine production in helmin-
thic infections and other situations marked by striking elevations of serum IgE levels.
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